Metabolism and structure activity data based drug design: Discovery of (-)SCH 53079 an analog of the potent cholesterol absorption inhibitor (-)SCH 48461

被引:47
作者
Dugar, S
Yumibe, N
Clader, JW
Vizziano, M
Huie, K
VanHeek, M
Compton, DS
Davis, HR
机构
[1] Schering-Plough Research Institute, Kenilworth, NJ 07033
关键词
D O I
10.1016/0960-894X(96)00214-4
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Based on the metabolism of the potent cholesterol absorption inhibitor (-) SCH48461 and structure activity relationship information, we designed and evaluated (-)SCH 53079. This compound was found to be equipotent to (-)SCH 48461 in both the cholesterol-fed hamster and rhesus monkey assays. Importantly, (-)SCH 53079 was metabolically more stable than (-)SCH 48461 and as desired had very low plasma levels and did not cause hepatic enzyme induction. Copyright (C) 1996 Elsevier Science Ltd
引用
收藏
页码:1271 / 1274
页数:4
相关论文
共 5 条
[1]   2-AZETIDINONES AS INHIBITORS OF CHOLESTEROL ABSORPTION [J].
BURNETT, DA ;
CAPLEN, MA ;
DAVIS, HR ;
BURRIER, RE ;
CLADER, JW .
JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (12) :1733-1736
[2]  
CLADER J, UNPUB 2 AZETIDINONE
[3]  
DAVIS HR, 1994, ATHEROSCLEROSIS, V109, P162
[4]   HYPOCHOLESTEROLEMIC ACTIVITY OF A NOVEL INHIBITOR OF CHOLESTEROL ABSORPTION, SCH-48461 [J].
SALISBURY, BG ;
DAVIS, HR ;
BURRIER, RE ;
BURNETT, DA ;
BOYKOW, G ;
CAPLEN, MA ;
CLEMMONS, AL ;
COMPTON, DS ;
HOOS, LM ;
MCGREGOR, DG ;
SCHNITZERPOLOKOFF, R ;
SMITH, AA ;
WEIG, BC ;
ZILLI, DL ;
CLADER, JW ;
SYBERTZ, EJ .
ATHEROSCLEROSIS, 1995, 115 (01) :45-63
[5]  
SCHINTZERPOLOKO.R, 1991, COMP BIOCH PHYSL, V197, P304